Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

23Andme Holding Co. (ME)

23Andme Holding Co. (ME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 85,406
  • Shares Outstanding, K 26,118
  • Annual Sales, $ 219,640 K
  • Annual Income, $ -666,700 K
  • EBIT $ -274 M
  • EBITDA $ 107 M
  • 60-Month Beta 1.15
  • Price/Sales 0.36
  • Price/Cash Flow 1.03
  • Price/Book 0.78

Options Overview Details

View History
  • Implied Volatility 102.71% ( +11.17%)
  • Historical Volatility 124.90%
  • IV Percentile 12%
  • IV Rank 14.40%
  • IV High 595.39% on 08/05/24
  • IV Low 19.85% on 01/16/24
  • Put/Call Vol Ratio 0.02
  • Today's Volume 1,169
  • Volume Avg (30-Day) 427
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 49,230
  • Open Int (30-Day) 46,281

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.97 +10.10%
on 11/25/24
4.17 -21.58%
on 12/09/24
+0.12 (+3.81%)
since 11/20/24
3-Month
2.65 +23.16%
on 11/19/24
7.88 -58.50%
on 10/02/24
-3.53 (-51.91%)
since 09/20/24
52-Week
2.65 +23.16%
on 11/19/24
19.34 -83.10%
on 12/28/23
-14.38 (-81.47%)
since 12/20/23

Most Recent Stories

More News
The Shake-Up at Intel

And cybersecurity consultant Dave Hatter helps us see what's really going on with all of our information.

META : 585.25 (-1.73%)
GOOGL : 191.41 (+1.54%)
NVDA : 134.70 (+3.08%)
GOOG : 192.96 (+1.72%)
AAPL : 254.49 (+1.88%)
AKAM : 95.89 (+1.39%)
ASML : 705.68 (-0.64%)
TSM : 197.21 (+1.32%)
MSFT : 436.60 (-0.10%)
INTC : 19.52 (+2.41%)
AMD : 119.21 (+0.28%)
ME : 3.27 (+6.86%)
23andMe and Mirador Therapeutics Forge Strategic Research Collaboration to Advance Precision Medicine in Immunology and Inflammation

23andMe and Mirador Therapeutics announce a collaboration to enhance precision medicine for immunology and inflammation diseases using genetic data.Quiver AI Summary23andMe Holding Co. and Mirador Therapeutics...

ME : 3.27 (+6.86%)
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation

ME : 3.27 (+6.86%)
23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

ME : 3.27 (+6.86%)
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

ME : 3.27 (+6.86%)
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

ME : 3.27 (+6.86%)
23andMe to Report Q2 FY2025 Financial Results

ME : 3.27 (+6.86%)
23andMe Regains Compliance With Nasdaq Listing Requirements

ME : 3.27 (+6.86%)
23andMe Appoints Three New Independent Directors to Board

ME : 3.27 (+6.86%)
ASML's Latest Chapter in the Semiconductor Story

We've also got a look at genetic testing company 23andMe .

TGT : 131.48 (+0.81%)
RAD.AX : 0.024 (+14.29%)
CVS : 44.36 (+1.32%)
INTC : 19.52 (+2.41%)
WBA : 9.55 (+2.14%)
ME : 3.27 (+6.86%)
BKNG : 5,048.59 (+1.37%)
AMZN : 224.92 (+0.73%)
ASML : 705.68 (-0.64%)

Business Summary

23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition...

See More

Key Turning Points

3rd Resistance Point 3.75
2nd Resistance Point 3.56
1st Resistance Point 3.42
Last Price 3.27
1st Support Level 3.09
2nd Support Level 2.90
3rd Support Level 2.76

See More

52-Week High 19.34
Fibonacci 61.8% 12.97
Fibonacci 50% 11.00
Fibonacci 38.2% 9.03
Last Price 3.27
52-Week Low 2.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar